| Name | Proteasome-IN-1 |
|---|---|
| Synonyms |
Benzeneacetamide, α-[(2-benzoylbenzoyl)[2-(1H-imidazol-5-yl)ethyl]amino]-3-cyano-N-(2,2-diphenylethyl)
ProteasomeIN1,Proteasome IN 1 |
| Description | Proteasome-IN-1 is a proteasome inhibitor extracted from patent WO 2013142376 A1. |
|---|---|
| Related Catalog | |
| Target |
Proteasome[1] |
| In Vitro | Proteasome-IN-1 is a proteasome inhibitor which can be useful for the treatment of cancer[1]. |
| References |
[1]. Jeffrey B. Smith, et al. Composition and methods for cell modulation. WO 2013142376 A1. |
| Molecular Formula | C42H35N5O3 |
|---|---|
| Molecular Weight | 657.76 |